Device Trial Radar · NCT07912892
Treating PHPT With the nPulse™ Vybrance™ PE System
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Nov 30, 2026
Primary completion
Nov 30, 2027
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- Pulse Biosciences, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 3, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to treat patients with the nPulse system and evaluate their outcomes following treatment. The study seeks to characterize patient outcomes and assess changes in serum calcium, ionized calcium, and parathyroid hormone (PTH) levels after treatment with nPulse.
Conditions
- Primary Hyperparathyroidism
Interventions
Ultrasound-Guided Parathyroid Nanosecond Pulsed Field Ablation (nsPFA)Device
Participants will undergo ultrasound-guided, non-surgical, non-thermal nanosecond pulse field ablation (nsPFA) of the targeted parathyroid gland using the nPulse™ system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Primary Safety Events (PSEs)Time frame: From procedure through 6 months post-procedure
- Normalization of corrected serum calcium and ionized calcium levelsTime frame: 6 months post-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sarasota Memorial Health Care System
Sarasota, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.